↓ Skip to main content

A comparison of the quality of informed consent for phase I oncology trials over a 30-year period

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, August 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter
16 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
7 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A comparison of the quality of informed consent for phase I oncology trials over a 30-year period
Published in
Cancer Chemotherapy and Pharmacology, August 2018
DOI 10.1007/s00280-018-3673-x
Pubmed ID
Authors

Laeeq Malik, James Cooper

X Demographics

X Demographics

The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Other 1 14%
Lecturer 1 14%
Student > Ph. D. Student 1 14%
Student > Master 1 14%
Researcher 1 14%
Other 0 0%
Unknown 2 29%
Readers by discipline Count As %
Medicine and Dentistry 2 29%
Linguistics 1 14%
Neuroscience 1 14%
Nursing and Health Professions 1 14%
Unknown 2 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 September 2018.
All research outputs
#4,099,079
of 25,342,911 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#206
of 2,564 outputs
Outputs of similar age
#72,679
of 341,453 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#3
of 23 outputs
Altmetric has tracked 25,342,911 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,564 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 341,453 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.